Abstract:Eukaryotic cell division is regulated by oscillating CDK activity, which must reach critical CDK threshold activity levels to progress through cell cycle stages. In low mitogen, low CDK environments cells exit the cell cycle into a non-proliferative quiescent state, G0, that plays essential roles in stem cell maintenance and cellular homeostasis. CIZ1 regulates cell cycle and epigenetic programmes, and CIZ1 ablation enhances genomic instability after release from quiescence. Here, we determined the mechanisms that promote genome instability in CIZ1 ablated cells using a combination of Fucci(CA) live cell imaging, cell-free DNA replication assays and DNA combing. Cell cycle dynamics are unaffected in CIZ1-/- (CIZ1 KO) fibroblasts; however, a specific post-quiescent phenotype is observed resulting in a reduced G1 phase and cell cycle length. The reduction in G1 length in CIZ1 KO cells is associated with increased cyclin E1/E2 and A2 expression, and enhanced phosphorylation of Rb leading to early restriction point bypass. CIZ1-/- cells are deficient in cyclin A chromatin binding and required increased cyclin-CDK activity for the initiation of DNA replication, which is associated with DNA replication stress in vitro and in vivo. Significantly, the CDK threshold for initiation of DNA replication was 2-fold higher in CIZ1 KO nuclei than parental controls. Importantly, addition of recombinant CIZ1 in vitro and in vivo promotes recruitment of cyclin A to chromatin and reinstates the CDK threshold for initiation of DNA replication, reversing DNA replication stress and increasing replication fork rates. Loss of CIZ1 is associated with dysregulated cyclin-CDK signalling, resulting in reduced G1 length, an increased CDK activity threshold required to promote initiation of DNA replication that results in DNA replication stress. These data suggest that CIZ1 facilitates recruitment of cyclin-CDK complexes to chromatin and contributes to the mechanisms that determine the threshold CDK activity required for the G1/S transition in post-quiescent cells. Taken together the data support a role for CIZ1 in the prevention of DNA replication stress and maintenance of genome stability.

Nuclear Matrix Protein Ciz1 and Cancer

RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability

CIZ1 regulates G1 length and the CDK threshold for initiation of DNA replication to prevent DNA replication stress

ZIC1 Modulates Cell-Cycle Distributions and Cell Migration Through Regulation of Sonic Hedgehog, PI 3 K and MAPK Signaling Pathways in Gastric Cancer

CIZ1 promoted the growth and migration of gallbladder cancer cells

Applications of novel monoclonal antibodies specific for Ciz 1 in evaluating its levels in cancer tissues and plasma from lung cancer patients

Zic1 Is Downregulated Through Promoter Hypermethylation, And Functions As A Tumor Suppressor Gene In Colorectal Cancer

Advances of NOTCH 1 Signaling in Cervical Cancer

Cyclin-dependent Kinase 9 Promotes Cervical Cancer Development Via AKT2/p53 Pathway.

Epigenetic deprogramming driven by disruption of CIZ1-RNA nuclear assemblies in early-stage breast cancers

MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21cip1

Cyclin I-like (CCNI2) is a Cyclin-Dependent Kinase 5 (CDK5) Activator and is Involved in Cell Cycle Regulation

ZWINT Promotes the Proliferation, Migration, and Invasion of Cervical Cancer Cells by Regulating the P53/p21 Signaling Pathway.

Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition

NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth

An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)

Cdkn1c (p57(kip2)) is A Direct Target of Ezh2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells

ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance by enhancing MYH9-dependent degradation of GSK-3β and integrin β1-mediated phosphorylation of FAK

MZT2A serves as a prognostic biomarker and promotes the progression of kidney renal clear cell carcinoma

CISD3 is a prognostic biomarker and therapeutic target in pan-cancer

Znhit1 causes cell cycle arrest and down-regulates CDK6 expression.